Insights

Gathering insights about Xeno…

Similar companies to Xeno

Xeno Tech Stack

Xeno uses 8 technology products and services including LinkedIn Ads, Docker, Webpack, and more. Explore Xeno's tech stack below.

LinkedIn Ads
Advertising
Docker
Containerization
Webpack
Development
Backbone.js
Javascript Frameworks
jQuery Migrate
Javascript Libraries
HTML
Programming Languages
TestNG
Testing And Qa
Google Analytics
Web Analytics

Media & News

Xenon Pharmaceuticals Sees Unusually Large Options Volume (NASDAQ:XENE)
Xenon Pharmaceuticals Inc. (NASDAQ: XENE - Get Free Report) was the target of some unusual options trading activity on Wednesday. Stock investors bought 4,063 put options on the company. This represents an increase of 2,362% compared to the average volume of 165 put options. Insider Activity at Xenon Pharmaceuticals In other Xenon Pharmaceuticals news, CEO Ian
Feb 05, 2026 | www.defenseworld.net
3 Biotech Stocks That Could Double In 2026
The biotech sector is one that's become red-hot, at least in recent years. After around a decade of stagnation, investors appear to be intent on increasing their exposure to top biotech names in the market, as growth in other sectors of the economy have led to valuations that now look more elevated than the biotech sector (in many cases).
Jan 20, 2026 | 247wallst.com
Polarean Expands Xenon MRI Platform into Cardiopulmonary Drug Development with Multi-Center PH-ILD Study
Innovative Trial Design to Directly Measure Microvascular Functional Effects of Inhaled Therapy at the Capillary level of Pulmonary Hypertension Patients with Interstitial Lung Disease (PH-ILD) Innovative Trial Design to Directly Measure Microvascular Functional Effects of Inhaled Therapy at the Capillary level of Pulmonary Hypertension Patients with Interstitial Lung Disease (PH-ILD)
Jan 20, 2026 | www.globenewswire.com
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
VANCOUVER, British Columbia and BOSTON, Jan. 16, 2026 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development, and commercialization of life-changing therapeutics for patients in need, today announced equity inducement grants to ten new non-officer employees consisting of an aggregate of 42,300 share options. All of the foregoing share options were approved by the Compensation Committee of the Company's Board of Directors with an effective date of January 15, 2026 and were granted as inducements material to the employees entering into employment with the Company in accordance with Nasdaq Listing Rule 5635(c)(4).
Jan 16, 2026 | www.globenewswire.com
Xenon Pharmaceuticals Inc. (XENE) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Xenon Pharmaceuticals Inc. (XENE) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Jan 12, 2026 | seekingalpha.com
Xenon Outlines Key Upcoming Milestones at the 2026 J.P. Morgan Healthcare Conference
VANCOUVER, British Columbia and BOSTON, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development and commercialization of life-changing therapeutics for patients in need, today outlined forward momentum across the Company's Phase 3 portfolio and discussed pipeline progress at the 2026 J.P. Morgan Healthcare Conference.
Jan 12, 2026 | www.globenewswire.com
Xenon to Present at the 44th Annual J.P. Morgan Healthcare Conference
VANCOUVER, British Columbia and BOSTON, Jan. 05, 2026 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development and commercialization of life-changing therapeutics for patients in need, today announced that the company will present at the 44th Annual J.P. Morgan Healthcare Conference, taking place in San Francisco, CA from January 12-15, 2026.
Jan 05, 2026 | www.globenewswire.com

Xeno's Email Address Formats

Xeno uses at least 2 format(s):

Xeno Email Formats	Example	Percentage
First@xeno.in	John@xeno.in	57%
First.Last@xeno.in	John.Doe@xeno.in	36%
Last@xeno.in	Doe@xeno.in	7%

Frequently Asked Questions

What is Xeno's stock symbol?

Xeno is a publicly traded company; the company's stock symbol is XENE.

What is Xeno's official website and social media links?

Xeno's official website is getxeno.com and has social profiles on LinkedIn.

What is Xeno's NAICS code?

Xeno's NAICS code is 5112 - Software Publishers.

How many employees does Xeno have currently?

As of January 2026, Xeno has approximately 131 employees across 5 continents, including AsiaNorth AmericaEurope. Key team members include Cto: M. J.Chief Growth Officer: F. M.President: L. S.. Explore Xeno's employee directory with LeadIQ.

What industry does Xeno belong to?

Xeno operates in the Software Development industry.

What technology does Xeno use?

Xeno's tech stack includes LinkedIn AdsDockerWebpackBackbone.jsjQuery MigrateHTMLTestNGGoogle Analytics.

What is Xeno's email format?

Xeno's email format typically follows the pattern of First@xeno.in. Find more Xeno email formats with LeadIQ.

When was Xeno founded?

Xeno was founded in 2015.

Xeno

Q: What is Xeno's official website and social media links?

Xeno's official website is getxeno.com. Xeno has social profiles on LinkedIn.

Q: How many employees does Xeno have currently?

Xeno has approximately 131 employees.

Q: What technology does Xeno use?

Xeno's tech stack includes Jenkins, Appium, Google Sheets, Webflow, Docker.

Software DevelopmentDelhi, India51-200 Employees

Xeno is an AI-powered customer engagement platform
purpose-built for retailers enabling them to Maximise Repeat
Revenue with 10x easier personalisation